DIASORIN
DiaSorin launches with CE mark the LIAISON SARS-CoV-2 TrimericS IgG test
DIASORIN
DiaSorin lancia con marcatura CE il LIAISON® SARS-CoV-2 TrimericS IgG
DIASORIN
DiaSorin has received BARDA Funding in support of submitting the SIMPLEXA COVID-19 Direct Kit for 510(k) clearance
DIASORIN
DiaSorin ha ricevuto un finanziamento dal governo americano per richiedere la certificazione 510(k) del test molecolare SIMPLEXA COVID-19 Direct
DIASORIN
Communication on total amount of voting rights
DIASORIN
Comunicazione ammontare complessivo diritti di voto
DIASORIN
DiaSorin S.p.A. - Allegato 3F
DIASORIN
DiaSorin received FDA approval for its LIAISON XL MUREX HIV Ab/Ag assay
DIASORIN
DiaSorin ha ricevuto l’approvazione a commercializzare il test LIAISON XL MUREX HIV Ab/Ag dalla Food and Drug Administration
DIASORIN
DiaSorin: North America growth drives up revenues and profitability in the first 9 months of 2020
DIASORIN
DiaSorin: la crescita del Nord America traina l’aumento di Ricavi e Redditività nei primi 9 mesi del 2020
DIASORIN
DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients
DIASORIN
DiaSorin lancia con marcatura CE il LIAISON® SARS-CoV-2 Ag per la rilevazione dell’antigene SARS-CoV-2 in pazienti sintomatici
DIASORIN
Conclusion treasury shares buy-back plan
DIASORIN
Conclusione programma acquisto azioni proprie
DIASORIN
Weekly report treasury shares buy-back
DIASORIN
Informativa settimanale acquisto azioni proprie
DIASORIN
Weekly report treasury shares buy-back
DIASORIN
Informativa settimanale acquisto azioni proprie 
DIASORIN
DiaSorin received FDA approval on 6 Hepatitis B tests, completing its Hepatitis offer in the US market
DIASORIN
DiaSorin ha ricevuto l’approvazione a commercializzare 6 test per l’epatite B dalla Food and Drug Administration americana
DIASORIN
DiaSorin’s LIAISON SARS-CoV-2 IgM test receives FDA Emergency Use Authorization for the U.S. market
DIASORIN
DiaSorin riceve l’approvazione ad uso di emergenza dalla Food and Drug Administration americana per il test LIAISON SARS-CoV-2 IgM negli Stati Uniti
DIASORIN
DiaSorin extends its current joint venture with the Chinese Government to open a new manufacturing and research site in China